Product
Supplier
Encyclopedia
Inquiry
Home > News > Company Dynamic
ECHEMI chemical news

Company Dynamic

Evonik Plans New Polyamide 12 Complex In Germany

Evonik Plans New Polyamide 12 Complex In Germany

2018-03-30

Evonik is planning to build a new production complex for the high-performance polymer polyamide 12 (PA 12). The German speciality chemicals firm intends to increase its overall PA 12 capacity by more than 50%. PA 12 finds application in attractive growth

Evonik Plans New Polyamide 12 Complex In Germany

Evonik Plans New Polyamide 12 Complex In Germany

2018-03-30

Evonik is planning to build a new production complex for the high-performance polymer polyamide 12 (PA 12). The German speciality chemicals firm intends to increase its overall PA 12 capacity by more than 50%. PA 12 finds application in attractive growth

Merck As The Best Bioprocessing Supplier In Asia

Merck As The Best Bioprocessing Supplier In Asia

2018-03-29

Merck, a leading science and technology company, was named the overall “Best Bioprocessing Supplier” and won the sub-category of “Best Bioprocessing Supplier Award for Single-use Systems” at the Asia-Pacific Bioprocessing Excellence Awards 2018 ceremony.

Syngene Signs R&D Agreement with GSK

Syngene Signs R&D Agreement with GSK

2018-03-29

Syngene International (www.syngeneintl.com), a global contract research services company, has formed a multiyear R&D agreement with GSK that will focus on accelerating the discovery of new drug candidates using Syngene's discovery services platforms.

GSK to Pay $13B for Novartis’ Stake in Consumer Healthcare JV

GSK to Pay $13B for Novartis’ Stake in Consumer Healthcare JV

2018-03-29

GlaxoSmithKline (GSK) has reached an agreement with Novartis for the buyout of Novartis’ 36.5% stake in their Consumer Healthcare Joint Venture for $13 billion. The Consumer Healthcare Joint Venture was formed as part of the three-part transaction...

Syngene Signs R&D Agreement with GSK

Syngene Signs R&D Agreement with GSK

2018-03-29

Syngene International (www.syngeneintl.com), a global contract research services company, has formed a multiyear R&D agreement with GSK that will focus on accelerating the discovery of new drug candidates using Syngene's discovery services platforms.

GSK to Pay $13B for Novartis’ Stake in Consumer Healthcare JV

GSK to Pay $13B for Novartis’ Stake in Consumer Healthcare JV

2018-03-29

GlaxoSmithKline (GSK) has reached an agreement with Novartis for the buyout of Novartis’ 36.5% stake in their Consumer Healthcare Joint Venture for $13 billion. The Consumer Healthcare Joint Venture was formed as part of the three-part transaction...

Bayer Pharmaceuticals Committed To India Growth

Bayer Pharmaceuticals Committed To India Growth

2018-03-29

India continues to be one of the key markets for Bayer Pharmaceuticals in Asia Pacific region and it plans to continue its clinical research, according to Mr. Claus Zieler, Senior Vice-President, Bayer Pharmaceuticals Asia Pacific.

Bayer Pharmaceuticals Committed To India Growth

Bayer Pharmaceuticals Committed To India Growth

2018-03-29

India continues to be one of the key markets for Bayer Pharmaceuticals in Asia Pacific region and it plans to continue its clinical research, according to Mr. Claus Zieler, Senior Vice-President, Bayer Pharmaceuticals Asia Pacific.

Abzena Expands ADC Capabilities

Abzena Expands ADC Capabilities

2018-03-29

Abzena has completed the facility remodeling for its new antibody-drug conjugate (ADC) GMP manufacturing suite at its Bristol, PA site.

Piramal Pharma Solutions Wins CMO Leadership Award

Piramal Pharma Solutions Wins CMO Leadership Award

2018-03-29

Piramal Pharma Solutions was recognized as a winner at the CMO Leadership Award 2018.

DRL Announces The Launch Of Anti-Allergy Drug In US Market

DRL Announces The Launch Of Anti-Allergy Drug In US Market

2018-03-29

Dr. Reddy’s Laboratories Ltd. (DRL) has announced that it has launched Levocetirizine Dihydrochloride Tablets USP, 5 mg, an over-the-counter therapeutic equivalent generic version of Xyzal Allergy 24HR Tablets, from UCB, in the US market as approved...

Mylan, Biocon Receive MAA

Mylan, Biocon Receive MAA

2018-03-29

Mylan and Biocon announced that their co-developed biosimilar insulin glargine Semglee™ has received marketing authorization approval from the European Commission (EC) following the positive recommendation by the Committee for Medicinal Products for...

Mylan, Biocon Receive MAA

Mylan, Biocon Receive MAA

2018-03-29

Mylan and Biocon announced that their co-developed biosimilar insulin glargine Semglee™ has received marketing authorization approval from the European Commission (EC) following the positive recommendation by the Committee for Medicinal Products for...

Lupin Launches Generic Safyral Tablets In The Us

Lupin Launches Generic Safyral Tablets In The Us

2018-03-29

Pharma major Lupin has announced the launch of its Tydemy Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3 mg/0.03 mg/0.451 mg and Levomefolate Calcium, 0.451 mg) having received an approval from the USFDA earlier...

Dupont Tate & Lyle To Expand Bio-Based Propanediol Production At US Facility

Dupont Tate & Lyle To Expand Bio-Based Propanediol Production At US Facility

2018-03-29

DuPont Tate & Lyle Bio Products, a food and industrial ingredients joint venture between DuPont and Tate & Lyle, is set to increase annual production of bio-based 1,3-propanediol by 35 million pounds at its facility in Loudon, Tennessee (USA).

Flavourings Firm Givaudan In Plant-Based Extract Acquisition

Flavourings Firm Givaudan In Plant-Based Extract Acquisition

2018-03-29

Swiss flavourings giant Givaudan has bolstered its natural ingredients offer after agreeing to buy a 40.6% stake in French firm Naturex for €522m (£457m), and launching a cash tender offer for the remaining shares.

Flavourings Firm Givaudan In Plant-Based Extract Acquisition

Flavourings Firm Givaudan In Plant-Based Extract Acquisition

2018-03-29

Swiss flavourings giant Givaudan has bolstered its natural ingredients offer after agreeing to buy a 40.6% stake in French firm Naturex for €522m (£457m), and launching a cash tender offer for the remaining shares.

Dupont Tate & Lyle To Expand Bio-Based Propanediol Production At US Facility

Dupont Tate & Lyle To Expand Bio-Based Propanediol Production At US Facility

2018-03-29

DuPont Tate & Lyle Bio Products, a food and industrial ingredients joint venture between DuPont and Tate & Lyle, is set to increase annual production of bio-based 1,3-propanediol by 35 million pounds at its facility in Loudon, Tennessee (USA).

LANXESS’ BAYFERROX Color Workshop Offers Specialized Pigments Education

LANXESS’ BAYFERROX Color Workshop Offers Specialized Pigments Education

2018-03-29

LANXESS Corporation’s Inorganic Pigments (IPG) business unit hosted its 27th annual BAYFERROX Color Workshop in Pittsburgh from March 6-8. Nearly two dozen professionals from concrete products manufacturers in North America participated in this ...

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.